News Home

What is the Market's View on BioCryst Pharmaceuticals Inc (BCRX) Stock's Price and Volume Trends Wednesday?

Wednesday, October 05, 2022 10:20 AM | InvestorsObserver Analysts
What is the Market's View on BioCryst Pharmaceuticals Inc (BCRX) Stock's Price and Volume Trends Wednesday?

The market has been high on BioCryst Pharmaceuticals Inc (BCRX) stock recently. BCRX gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bullish
BioCryst Pharmaceuticals Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on BCRX!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With BCRX Stock Today?

BioCryst Pharmaceuticals Inc (BCRX) stock has gained 1.14% while the S&P 500 is down -1.64% as of 10:16 AM on Wednesday, Oct 5. BCRX has gained $0.16 from the previous closing price of $14.07 on volume of 422,715 shares. Over the past year the S&P 500 is down -13.30% while BCRX has gained 6.91%. BCRX lost -$1.14 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for BioCryst Pharmaceuticals Inc click here.

More About BioCryst Pharmaceuticals Inc

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, with the aim of blocking key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology. Click Here to get the full Stock Report for BioCryst Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App